Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies Journal Article


Authors: Luo, W.; Dou, F.; Rodina, A.; Chip, S.; Kim, J.; Zhao, Q.; Moulick, K.; Aguirre, J.; Wu, N.; Greengard, P.; Chiosis, G.
Article Title: Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies
Abstract: Neurodegeneration, a result of multiple dysregulatory events, is a lengthy multistep process manifested by accrual of mutant variants and abnormal expression, posttranslational modification, and processing of certain proteins. Accumulation of these dysregulated processes requires a mechanism that maintains their functional stability and allows the evolution of the neurodegenerative phenotype. In malignant cells, the capacity to buffer transformation has been attributed to heat-shock protein 90 (Hsp90). Although normal proteins seem to require limited assistance from the chaperone, their aberrant counterparts seem to be highly dependent on Hsp90. Whereas enhanced Hsp90 affinity for mutated or functionally deregulated client proteins has been observed for several oncoproteins, it is unknown whether Hsp90 plays a similar role for neuronal proteins and thus maintains and facilitates the transformed phenotype in neurodegenerative diseases. Tauopathies are neurodegenerative diseases characterized by aberrant phosphorylation and/or expression of Tau protein, leading to a time-dependent accumulation of Tau aggregates and subsequent neuronal death. Here, we show that the stability of p35, a neuronal protein that activates cyclin-dependent protein kinase 5 through complex formation leading to aberrant Tau phosphorylation, and that of mutant but not WT Tau protein is maintained in tauopathies by Hsp90. Inhibition of Hsp90 in cellular and mouse models of tauopathies leads to a reduction of the pathogenic activity of these proteins and results in elimination of aggregated Tau. The results identify important roles played by Hsp90 in maintaining and facilitating the degenerative phenotype in these diseases and provide a common principle governing cancer and neurodegenerative diseases. © 2007 by The National Academy of Sciences of the USA.
Keywords: controlled study; protein expression; protein phosphorylation; genetics; mutation; nonhuman; mutant protein; binding affinity; protein function; animal cell; mouse; phenotype; animal; metabolism; animals; animal tissue; complex formation; proteasome; proteasome endopeptidase complex; protein degradation; animal model; protein binding; protein stability; enzyme activation; pathology; cercopithecus aethiops; cos cells; phosphorylation; drug antagonism; protein processing; cell transformation; rat; cell strain cos1; cercopithecus; heat shock protein 90; hsp90 heat-shock proteins; rats; phosphotransferase; degenerative disease; phosphotransferases; tau protein; nerve degeneration; neurodegeneration; nerve cell necrosis; cyclin dependent kinase 5; tauopathy; cyclin-dependent protein kinase 5; tau; tau proteins; tauopathies
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 104
Issue: 22
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2007-05-29
Start Page: 9511
End Page: 9516
Language: English
DOI: 10.1073/pnas.0701055104
PUBMED: 17517623
PROVIDER: scopus
PMCID: PMC1890525
DOI/URL:
Notes: --- - "Cited By (since 1996): 63" - "Export Date: 17 November 2011" - "CODEN: PNASA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nian Wu
    32 Wu
  2. Kamalika Moulick
    16 Moulick
  3. Gabriela Chiosis
    279 Chiosis
  4. Julia Aguirre
    15 Aguirre
  5. Joungnam Kim
    14 Kim